Abstract:Detecting and mapping metabolism in tissues represents a major step in detecting, characterizing, treating and understanding cancers. Recently introduced deuterium metabolic imaging techniques could offer a noninvasive route for the metabolic imaging of animals and humans, based on using 2H magnetic resonance spectroscopic imaging (MRSI) to detect the uptake of deuterated glucose and the fate of its metabolic products. In this study, 2H6,6′-glucose was administered to mice cohorts that had been orthotopically implanted with two different models of pancreatic ductal adenocarcinoma (PDAC), involving PAN-02 and KPC cell lines. As the tumors grew, 2H6,6′-glucose was administered as bolii into the animals' tail veins, and 2H MRSI images were recorded at 15.2 T. 2D phase-encoded chemical shift imaging experiments could detect a signal from this deuterated glucose immediately after the bolus injection for both the PDAC models, reaching a maximum in the animals' tumors ~ 20 min following administration, and nearly total decay after ~ 40 min. The main metabolic reporter of the cancers was the 2H3,3′-lactate signal, which MRSI could detect and localize on the tumors when these were 5 mm or more in diameter. Lactate production time traces varied slightly with the animal and tumor model, but in general lactate peaked at times of 60 min or longer following injection, reaching concentrations that were ~ 10-fold lower than those of the initial glucose injection. This 2H3,3′-lactate signal was only visible inside the tumors. 2H-water could also be detected as deuterated glucose's metabolic product, increasing throughout the entire time course of the experiment from its ≈10 mM natural abundance background. This water resonance could be imaged throughout the entire abdomen of the animals, including an enhanced presence in the tumor, but also in other organs like the kidney and bladder. These results suggest that deuterium MRSI may serve as a robust, minimally invasive tool for the monitoring of metabolic activity in pancreatic tumors, capable of undergoing clinical translation and supporting decisions concerning treatment strategies. Comparisons with in vivo metabolic MRI experiments that have been carried out in other animal models are presented and their differences/similarities are discussed.

Nimg-69. Interrogation Of Glioblastoma Fatty-Acid Synthesis And Metabolism With Deuterium Metabolic Imaging

Using Arterial–venous Analysis to Characterize Cancer Metabolic Consumption in Patients

Nimg-19. Deuterium Metabolic Imaging Interrogates The Histone H3K27M Mutation And Provides An Early Readout Of Response To Therapy In Diffuse Midline Gliomas

Mapping of exogenous choline uptake and metabolism in rat glioblastoma using deuterium metabolic imaging (DMI)

Nimg-30. Deuterium Metabolic Imaging (Dmi) Shows A Strong Relation Between Tumor Grade And Glucose Metabolism In Primary Brain Tumors

Deuterium metabolic imaging differentiates glioblastoma metabolic subtypes and detects early response to chemoradiotherapy

Nimg-32. Oral Administration Of Deuterated Choline As A New Approach To Provide High Tumor-To-Brain Image Contrast In Deuterium Metabolic Imaging (Dmi)

Deuterium Metabolic Imaging Phenotypes Mouse Glioblastoma Heterogeneity Through Glucose Turnover Kinetics

Biom-23. Deuterium Metabolic Imaging Of Response To Precision Therapy In Braf-V600E Mutant Gliomas

Tmet-02. Cell-Intrinsic Metabolic Phenotypes Identified In Glioblastoma Patients Using Mass Spectrometry Imaging Of 13C-Labeled Glucose Metabolism

Tmet-23. Mass Spectrometry-Based Metabolic Profiling And Imaging Of Astrocyte And Glioblastoma Invasive Margin Cells

Deuterium MRSI characterizations of glucose metabolism in orthotopic pancreatic cancer mouse models

Assessing fatty acid-induced lipotoxicity and its therapeutic potential in glioblastoma using stimulated Raman microscopy

Localized Metabolomic Gradients in Patient-Derived Xenograft Models of Glioblastoma

Molecular imaging of tumor metabolism: Insight from pyruvate- and glucose-based deuterium MRI studies

Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-13C]Pyruvate Demonstrates Heterogeneity in Lactate Labeling: A Proof of Principle Study

Tmic-53. Use Of Cerebral Open-Flow Microperfusion To Identify Potential Oncometabolite, L-2-Hydroxyglutarate, In Glioblastoma Chemotherapy Adaptation

Combining Amide Proton Transfer-Weighted and Arterial Spin Labeling Imaging to Differentiate Solitary Brain Metastases from Glioblastomas

Lipid Metabolism in Glioblastoma: From De Novo Synthesis to Storage

Deuterium MRI of serine metabolism in mouse models of glioblastoma

Improving deuterium metabolic imaging (DMI) signal‐to‐noise ratio by spectroscopic multi‐echo bSSFP: A pancreatic cancer investigation